Stephen Mahoney is the New CEO and President of Viridian Therapeutics
Viridian Therapeutics (NASDAQ: VRDN) has announced the appointment of Stephen Mahoney as its new CEO and President, effective immediately. Mahoney brings over two decades of experience in the biopharmaceutical industry, having previously served as president, CFO, and operating officer of Magenta Therapeutics. Scott Myers, the former President and CEO, stepped...